These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro. Wallis RM; Corbin JD; Francis SH; Ellis P Am J Cardiol; 1999 Mar; 83(5A):3C-12C. PubMed ID: 10078537 [TBL] [Abstract][Full Text] [Related]
7. Involvement of cyclic nucleotides in renal artery smooth muscle relaxation. Karsten AJ; Derouet H; Ziegler M; Eckert RE Urol Res; 2003 Feb; 30(6):367-73. PubMed ID: 12599016 [TBL] [Abstract][Full Text] [Related]
8. Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes. Castro LR; Verde I; Cooper DM; Fischmeister R Circulation; 2006 May; 113(18):2221-8. PubMed ID: 16651469 [TBL] [Abstract][Full Text] [Related]
9. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway. Eckly AE; Lugnier C Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194 [TBL] [Abstract][Full Text] [Related]
10. Cyclic nucleotide phosphodiesterases in rabbit detrusor smooth muscle. Qiu Y; Kraft P; Craig EC; Liu X; Haynes-Johnson D Urology; 2002 Jan; 59(1):145-9. PubMed ID: 11796312 [TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase in heart and vessels: from physiology to diseases. Fu Q; Wang Y; Yan C; Xiang YK Physiol Rev; 2024 Apr; 104(2):765-834. PubMed ID: 37971403 [TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase regulation of nitric oxide signaling. Kass DA; Takimoto E; Nagayama T; Champion HC Cardiovasc Res; 2007 Jul; 75(2):303-14. PubMed ID: 17467673 [TBL] [Abstract][Full Text] [Related]
13. Effects of various phosphodiesterase-inhibitors, forskolin, and sodium nitroprusside on porcine detrusor smooth muscle tonic responses to muscarinergic stimulation and cyclic nucleotide levels in vitro. Truss MC; Uckert S; Stief CG; Kuczyk M; Schulz-Knappe P; Forssmann WG; Jonas U Neurourol Urodyn; 1996; 15(1):59-70. PubMed ID: 8696357 [TBL] [Abstract][Full Text] [Related]
15. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors. Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708 [TBL] [Abstract][Full Text] [Related]
16. Cyclic nucleotide phosphodiesterases in heart and vessels: A therapeutic perspective. Bobin P; Belacel-Ouari M; Bedioune I; Zhang L; Leroy J; Leblais V; Fischmeister R; Vandecasteele G Arch Cardiovasc Dis; 2016; 109(6-7):431-43. PubMed ID: 27184830 [TBL] [Abstract][Full Text] [Related]
17. Structural Modifications of Nimodipine Lead to Novel PDE1 Inhibitors with Anti-pulmonary Fibrosis Effects. Huang MX; Tian YJ; Han C; Liu RD; Xie X; Yuan Y; Yang YY; Li Z; Chen J; Luo HB; Wu Y J Med Chem; 2022 Jun; 65(12):8444-8455. PubMed ID: 35666471 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of a novel, potent and selective phosphodiesterase 5 inhibitor, DMPPO: in vitro and in vivo characterization. Delpy E; le Monnier de Gouville AC Br J Pharmacol; 1996 Jul; 118(6):1377-84. PubMed ID: 8832060 [TBL] [Abstract][Full Text] [Related]
19. Cyclic guanosine monophosphate compartmentation in human vascular smooth muscle cells. Feiteiro J; Verde I; Cairrão E Cell Signal; 2016 Mar; 28(3):109-116. PubMed ID: 26689737 [TBL] [Abstract][Full Text] [Related]
20. Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells. Wharton J; Strange JW; Møller GM; Growcott EJ; Ren X; Franklyn AP; Phillips SC; Wilkins MR Am J Respir Crit Care Med; 2005 Jul; 172(1):105-13. PubMed ID: 15817798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]